X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
KDL Biotech Ltd.
BSE CODE: 532291   |   NSE CODE: NA   |   ISIN CODE : INE746A01010   |   16-Mar-2015 Hrs IST
BSE NSE
Rs. 2.14
0 ( 0% )
 
Prev Close ( Rs.)
2.14
Open ( Rs.)
2.14
 
High ( Rs.)
2.14
Low ( Rs.)
2.14
 
Volume
4811
Week Avg.Volume
2454
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
765
 
52 WK High-Low Range(Rs.)
Particulars Mar 2012Mar 2011Mar 2010Sep 2008Sep 2007
Operational & Financial Ratios          
   Earnings Per Share (Rs)-7.16  -26.76  -7.08  -8.79  -8.08  
   CEPS(Rs)-3.36  -17.46  -1.92  -5.92  -2.00  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)-24.62  -17.46  9.30  16.38  -0.16  
   Tax Rate(%)0.00  -13.59  -0.13  -0.20  -0.48  
Margin Ratios          
   Core EBITDA Margin(%)-7.58  -56.34  -25.53  -15.74  -6.01  
   EBIT Margin(%)-38.31  -171.82  -35.33  -17.85  -0.30  
   Pre Tax Margin(%)-63.15  -195.04  -42.86  -35.04  -7.51  
   PAT Margin (%)-63.15  -221.53  -42.92  -35.11  -7.54  
   Cash Profit Margin (%)-29.64  -144.55  -11.63  -23.65  -1.87  
Performance Ratios          
   ROA(%)-28.21  -78.59  -16.21  -16.41  -9.49  
   ROE(%)0.00  0.00  -55.12  -108.11  0.00  
   ROCE(%)-108.39  -101.90  -15.27  -11.54  -0.57  
   Asset Turnover(x)0.45  0.35  0.38  0.47  1.26  
   Sales/Fixed Asset(x)0.18  0.19  0.26  0.42  1.29  
   Working Capital/Sales(x)-0.26  -0.30  -5.55  4.60  22.49  
Efficiency Ratios          
   Fixed Capital/Sales(x)5.69  5.33  3.78  2.37  0.78  
   Receivable days2.08  2.29  5.11  71.62  55.32  
   Inventory Days34.92  38.80  39.94  105.73  44.67  
   Payable days425.93  647.98  354.16  343.20  98.86  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-1.09  -0.31  -6.47  -1.97  -7.18  
   Price/Book(x)-0.15  -0.31  1.33  0.71  -89.64  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)2.59  2.56  2.25  1.60  0.63  
   EV/Core EBITDA(x)-52.39  -4.53  -10.46  -23.64  11.04  
   EV/EBIT(x)-6.56  -1.46  -6.18  -8.46  -197.33  
   EV/CE(x)1.21  1.11  0.88  0.81  0.73  
   M Cap / Sales0.33  0.46  0.78  0.49  0.14  
Growth Ratio          
   Net Sales Growth(%)-6.83  -25.98  -32.49  -66.47  206.93  
   Core EBITDA Growth(%)91.84  -94.07  -114.84  -139.82  489.76  
   EBIT Growth(%)79.07  -256.29  -30.34  -1888.04  91.15  
   PAT Growth(%)73.24  -278.13  19.51  -55.97  -20.11  
   EPS Growth(%)73.24  -278.13  19.51  -8.78  -20.11  
Financial Stability Ratios          
   Total Debt/Equity(x)-1.02  -1.43  2.57  1.63  -308.82  
   Current Ratio(x)0.06  0.06  0.73  1.84  1.13  
   Quick Ratio(x)0.04  0.04  0.60  1.50  0.66  
   Interest Cover(x)-1.54  -7.40  -4.69  -1.04  -0.04  
   Total Debt/Mcap(x)6.85  4.64  1.92  2.29  3.44